CAR T-cell therapies have saved lives in patients with blood cancers, but there has been a downside: T cells that enter solid tumors can stop working due to a phenomenon called T cell exhaustion. Now scientists have found a way of counteracting T cell exhaustion and making CAR T cell therapies more effective.